Shilajatu for improvement in quality of life in patients of diabetes mellitus


Neha Lamba

International Journal of Traditional and Complementary Medicine

Ayurvedic Medical Officer, ESI Hospital, Jalandhar, Punjab

As per WHO, in South-east Asia region alone 96 million people are estimated to be suffering from diabetes. Due to sedentary lifestyle and stress full nature of work, associated risk factors such as being overweight or obese, the number of diabetic patients is increasing. Diabetes is an important cause of blindness, kidney failure, lower limb amputation and other long-term consequences that impact on quality of life significantly. Continuous research is being done by scientists of various fields in order to achieve an effective cure of the disease and to improve quality of life. A great deal of work has also been done by Ayurvedic research scholars on various herbal and mineral drugs to find an effective treatment for diabetes generally reffered to as Prameha. Shilajatu is one such drug which has been described for the management of Prameha in Ayurveda texts. The present study was conducted to evaluate the efficacy of Shilajatu in the improving the quality of life in patients of Prameha. Twenty two diabetic patients were selected for the study. The results were assessed in terms of symptomatic relief on the basis of scoring system, as per the Questionnaire on Quality of Life. Statistically highly significant improvement (p <0.001) was observed on physical domain. Statistically significant improvement was observed on psychological domain with p<0.001. In terms of Social Relationships Domain also, highly significant improvement, with p <0.001 was observed. Highly significant improvement was observed in overall quality of life statistically with p <0.001. The study revealed that Shilajatu can be used as a drug in the management of Prameha to improve the quality of life of patients.

Keywords: Diabetes, Prameha, quality of life, Shilajatu, WHO-QOL-BREF

Free Full-text PDF